Embryonic Stem Cell-Derived Extracellular Vesicles Enhance the Therapeutic Effect of Mesenchymal Stem Cells.

Yan Zhang,Jia Xu,Siying Liu,Meikuang Lim,Shuang Zhao,Kaige Cui,Kaiyue Zhang,Lingling Wang,Qian Ji,Zhongchao Han,Deling Kong,Zongjin Li,Na Liu
DOI: https://doi.org/10.7150/thno.35305
IF: 11.6
2019-01-01
Theranostics
Abstract:Background: Embryonic stem cells (ES) have a great potential for cell-based therapies in a regenerative medicine. However, the ethical and safety issues limit its clinical application. ES-derived extracellular vesicles (ES-EVs) have been reported suppress cellular senescence. Mesenchymal stem cells (MSCs) are widely used for clinical cell therapy. In this study, we investigated the beneficial effects of ES-EVs on aging MSCs to further enhancing their therapeutic effects. Methods:In vitro, we explored the rejuvenating effects of ES-EVs on senescent MSCs by senescence-associated β-gal (SA-β-gal) staining, immunostaining, and DNA damage foci analysis. The therapeutic effect of senescent MSC pre-treated with ES-EVs was also evaluated by using mouse cutaneous wound model. Results: We found that ES-EVs significantly rejuvenated the senescent MSCs in vitro and improve the therapeutic effects of MSCs in a mouse cutaneous wound model. In addition, we also identified that the IGF1/PI3K/AKT pathway mediated the antisenescence effects of ES-EVs on MSCs. Conclusions: Our results suggested that ES cells derived-extracellular vesicles possess the antisenescence properties, which significantly rejuvenate the senescent MSCs and enhance the therapeutic effects of MSCs. This strategy might emerge as a novel therapeutic strategy for MSCs clinical application.
What problem does this paper attempt to address?